Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.3700
-0.0200 (-5.13%)
At close: May 20, 2026

BOM:531752 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
----24.74
Other Revenue
25.5811.987.892.50.07
25.5811.987.892.524.81
Revenue Growth (YoY)
113.58%51.78%215.26%-89.91%52.90%
Cost of Revenue
----20.15
Gross Profit
25.5811.987.892.54.66
Selling, General & Admin
2.831.680.841.750.54
Other Operating Expenses
13.19133.672.721.08
Operating Expenses
16.0114.684.514.461.62
Operating Income
9.57-2.73.38-1.963.04
Other Non Operating Income (Expenses)
0----
EBT Excluding Unusual Items
9.57-2.73.38-1.963.04
Gain (Loss) on Sale of Investments
-----3.12
Gain (Loss) on Sale of Assets
--15.926.63-
Pretax Income
9.57-2.719.314.67-0.09
Income Tax Expense
0.970.23-0.11-
Net Income
8.6-2.9319.314.56-0.09
Net Income to Common
8.6-2.9319.314.56-0.09
Net Income Growth
--323.86%--
Shares Outstanding (Basic)
999761761761761
Shares Outstanding (Diluted)
999761761761761
Shares Change (YoY)
31.27%----
EPS (Basic)
0.01-0.000.030.01-0.00
EPS (Diluted)
0.01-0.000.030.01-0.00
EPS Growth
--323.91%--
Gross Margin
100.00%100.00%100.00%100.00%18.79%
Operating Margin
37.40%-22.54%42.87%-78.19%12.24%
Profit Margin
33.60%-24.44%244.67%181.98%-0.35%
EBIT
9.57-2.73.38-1.963.04
EBIT Margin
37.40%-22.54%42.87%-78.19%12.24%
Effective Tax Rate
10.17%--2.42%-
Revenue as Reported
25.5811.9823.829.1324.81
Source: S&P Global Market Intelligence. Standard template. Financial Sources.